Biotech entity
Bharat Innovates 2026 is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories. Source depth averages 2.3 original sources per story, versus 4 across the same-window beat baseline. Across a 139-day span, the pace is roughly 0.2 stories per week.
Last mentioned: Aug 7, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 67 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Bharat Innovates 2026 is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories. Source depth averages 2.3 original sources per story, versus 4 across the same-window beat baseline. Across a 139-day span, the pace is roughly 0.2 stories per week. The clearest coverage concentration is fda-approval: 1 of 3 stories, with the rest divided among 2 other categories. Their average consequence score of 6.3 sits level with the 6.3 recorded across the beat in that window. We currently track 3 Biotech stories that mention MedTech, published between March 22, 2026 and August 7, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 290 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering MedTech. Shared-story counts are live from our verified record — not editorial picks.
The 9th India Medical Device 2026 conference offers biotech and pharma companies a clear signal to diversify into the device sector, as the government pushes for domestic manufacturing and innovation. Regulatory sentiment is shifting to support local production, opening new market adjacencies.
At Bharat Innovates 2026 in Nice, Union Minister Piyush Goyal committed the entire second edition of India's Startup Fund of Funds to deep tech, including medtech and healthcare. The move promises a major boost for Indian biotech startups, with 3,000 innovators invited to shape policy and access global markets through Free Trade Agreements. For biotech founders, this signals unprecedented government backing and a direct channel to influence the funding and regulatory landscape.
Source: calcuttanews.net · aninews.in
Union Minister Jitendra Singh has highlighted a significant boom in India's pharmaceutical and medical technology sectors, marking a strategic pivot toward national self-reliance. This growth reflects a broader movement to reduce import dependency and establish India as a global manufacturing hub for advanced medical solutions.
MedTech is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
